Aconine inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aconine inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression
Authors
Keywords
-
Journal
ACTA PHARMACOLOGICA SINICA
Volume 37, Issue 2, Pages 255-263
Publisher
Springer Nature
Online
2015-11-23
DOI
10.1038/aps.2015.85
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pin1 Regulates Osteoclast Fusion Through Suppression of the Master Regulator of Cell Fusion DC-STAMP
- (2014) Rabia Islam et al. JOURNAL OF CELLULAR PHYSIOLOGY
- DC-STAMP, the Key Fusion-Mediating Molecule in Osteoclastogenesis
- (2014) Chengcheng Zhang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Sinomenine induces apoptosis in RAW 264.7 cell-derived osteoclasts in vitro via caspase-3 activation
- (2013) Long-gang He et al. ACTA PHARMACOLOGICA SINICA
- Zinc inhibits osteoclast differentiation by suppression of Ca2+-Calcineurin-NFATc1 signaling pathway
- (2013) Kwang Park et al. Cell Communication and Signaling
- Lentivirus-mediated RNA interference of DC-STAMP expression inhibits the fusion and resorptive activity of human osteoclasts
- (2013) Zhiyong Zeng et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Development and assessment of a complete-detoxication strategy for Fuzi (lateral root of Aconitum carmichaeli) and its application in rheumatoid arthritis therapy
- (2013) Peijian Tong et al. JOURNAL OF ETHNOPHARMACOLOGY
- Norisoboldine Suppresses Osteoclast Differentiation through Preventing the Accumulation of TRAF6-TAK1 Complexes and Activation of MAPKs/NF-κB/c-Fos/NFATc1 Pathways
- (2013) Zhi-feng Wei et al. PLoS One
- Sinomenine Suppresses Osteoclast Formation and Mycobacterium tuberculosis H37Ra-Induced Bone Loss by Modulating RANKL Signaling Pathways
- (2013) Xiaojuan Li et al. PLoS One
- Membrane-bound receptor activator of NFκB ligand (RANKL) activity displayed by osteoblasts is differentially regulated by osteolytic factors
- (2012) Preetinder P. Singh et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Therapeutic targeting of osteoclast function and pathways
- (2011) Matthew L Broadhead et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Regulation of human osteoclast development by dendritic cell-specific transmembrane protein (DC-STAMP)
- (2011) Ya-Hui Chiu et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis
- (2011) Aline G. Costa et al. Nature Reviews Rheumatology
- Inhibitory effect of cantharidin on osteoclast differentiation and bone resorption
- (2010) Myung Hee Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Aconite poisoning
- (2009) Thomas Y.K. Chan CLINICAL TOXICOLOGY
- Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation
- (2009) Insun Song et al. FEBS LETTERS
- Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation
- (2009) Takako Negishi-Koga et al. IMMUNOLOGICAL REVIEWS
- Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts
- (2009) Myung Hee Kim et al. JOURNAL OF CELLULAR PHYSIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now